Glucagon-like peptide-1-responsive catecholamine neurons in the area postrema link peripheral glucagon-like peptide-1 with central autonomic control sites

被引:0
|
作者
Yamamoto, H
Kishi, T
Lee, CE
Choi, BJ
Fang, H
Hollenberg, AN
Drucker, DJ
Elmquist, JK
机构
[1] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Endocrinol, Boston, MA 02215 USA
[2] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA
[3] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02215 USA
[4] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Program Neurosci, Boston, MA 02215 USA
[5] Toronto Gen Hosp, Dept Med, Toronto, ON M5G 2C4, Canada
[6] Univ Toronto, Banting & Best Diabet Ctr, Toronto, ON M5G 2C4, Canada
来源
JOURNAL OF NEUROSCIENCE | 2003年 / 23卷 / 07期
关键词
GLP-1; area postrema; tyrosine hydroxylase; blood-brain barrier; insulin; c-Fos; catecholamine neurons; autonomic regulatory system;
D O I
暂无
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Glucagon-like peptide-1 (GLP-1) released from the gut is an incretin that stimulates insulin secretion. GLP-1 is also a brain neuropeptide that has diverse central actions, including inhibition of food and water intake, gastric emptying, and stimulation of neuroendocrine responses characteristic of visceral illness. Both intravenous and intracerebroventricular administration of GLP-1 receptor (GLP-1R) agonists increase blood pressure and heart rate and induce Fos-like immunoreactivity (Fos-IR) in autonomic regulatory sites in the rat brain. The area postrema (AP) is a circumventricular organ and has been implicated in processing visceral sensory information. GLP-1Rs are densely expressed in the AP, and peripheral GLP-1R agonists induce Fos-IR in AP neurons to a greater degree than intracerebroventricular administration. Because the AP lacks a blood-brain barrier, we hypothesized that the AP is a key site for peripheral GLP-1 to activate central autonomic regulatory sites. In this study, we found that many tyrosine hydroxylase (TH)-containing neurons in the AP expressed GLP-1Rs and Fos-IR after intravenous GLP-1R agonists. Furthermore, intravenous but not intracerebroventricular GLP-1R agonists induced TH transcription in the AP in vivo. In addition, GLP-1R agonists directly activated TH transcription in an in vitro cell system. Finally, we found that GLP-1-responsive TH neurons in the AP innervate autonomic control sites, including the parabrachial nucleus, nucleus of solitary tract, and ventrolateral medulla. These findings suggest that catecholamine neurons in the AP link peripheral GLP-1 and central autonomic control sites that mediate the diverse neuroendocrine and autonomic actions of peripheral GLP-1.
引用
收藏
页码:2939 / 2946
页数:8
相关论文
共 50 条
  • [41] Glucagon-like Peptide-1 and the Central/Peripheral Nervous System: Crosstalk in Diabetes
    Muscogiuri, Giovanna
    DeFronzo, Ralph A.
    Gastaldelli, Amalia
    Holst, Jens J.
    TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2017, 28 (02): : 88 - 103
  • [42] Central, but not peripheral, glucagon-like peptide-1 inhibits crop emptying in chicks
    Tachibana, T
    Matsumoto, M
    Furuse, M
    Hasegawa, S
    Yoshizawa, F
    Sugahara, K
    COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY A-MOLECULAR & INTEGRATIVE PHYSIOLOGY, 2003, 134 (04): : 777 - 781
  • [43] A role for central glucagon-like peptide-1 in temperature regulation
    OShea, D
    Gunn, I
    Chen, XH
    Bloom, S
    Herbert, J
    NEUROREPORT, 1996, 7 (03) : 830 - 832
  • [44] Role of central glucagon-like peptide-1 in stress regulation
    Ghosal, Sriparna
    Myers, Brent
    Herman, James P.
    PHYSIOLOGY & BEHAVIOR, 2013, 122 : 201 - 207
  • [45] Computational Peptide Design Cotargeting Glucagon and Glucagon-like Peptide-1 Receptors
    Vishnoi, Shubham
    Bhattacharya, Shayon
    Walsh, Erica M.
    Okoh, Grace Ilevbare
    Thompson, Damien
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2023, 63 (15) : 4934 - 4947
  • [46] Glucagon-like peptide-1 and glucagon-like peptide-2 regulation during human liver regeneration
    Ammann, Markus
    Santol, Jonas
    Pereyra, David
    Kalchbrenner, Tamara
    Wuerger, Tanja
    Laengle, Johannes
    Smoot, Rory L.
    Hulla, Wolfgang
    Laengle, Friedrich
    Starlinger, Patrick
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [47] Direct and indirect mechanisms regulating secretion of glucagon-like peptide-1 and glucagon-like peptide-2
    Brubaker, PL
    Anini, Y
    CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2003, 81 (11) : 1005 - 1012
  • [48] Glucagon-like peptide-1 and glucagon-like peptide-2 regulation during human liver regeneration
    Markus Ammann
    Jonas Santol
    David Pereyra
    Tamara Kalchbrenner
    Tanja Wuerger
    Johannes Laengle
    Rory L. Smoot
    Wolfgang Hulla
    Friedrich Laengle
    Patrick Starlinger
    Scientific Reports, 13
  • [49] Glucagon-like peptide-2 inhibits antral emptying in man, but is not as potent as glucagon-like peptide-1
    Nagell, CF
    Wettergren, A
    Pedersen, JF
    Mortensen, D
    Holst, JJ
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2004, 39 (04) : 353 - 358
  • [50] GLUCAGON-LIKE PEPTIDE-1 HAS NO GLUCAGON-LIKE EFFECT ON PLASMA-GLUCOSE AND INSULIN
    GHIGLIONE, M
    UTTENTHAL, LO
    GEORGE, SK
    BLOOM, SR
    DIABETOLOGIA, 1984, 27 (02) : A278 - A279